Third trimester re-screening for gestational diabetes in morbidly obese women despite earlier negative test can reveal risks for obstetrical complications.
Abu Shqara RaneenShany OrYara Nakhleh FrancisYifat WienerLior LowensteinMaya Frank WolfPublished in: The journal of obstetrics and gynaecology research (2022)
, GDM in a previous pregnancy or fasting glucose >95 mg/dl. Women diagnosed with GDM at >34 weeks following normal glucose screening at 24-28 weeks are at higher risk for adverse perinatal outcomes. For women with morbid obesity, or suspected macrosomia or polyhydramnios in the late third trimester, and normal glucose screening in the second trimester, retesting should be considered.
Keyphrases
- pregnancy outcomes
- pregnant women
- gestational age
- blood glucose
- preterm birth
- weight loss
- bariatric surgery
- insulin resistance
- obese patients
- metabolic syndrome
- polycystic ovary syndrome
- type diabetes
- adipose tissue
- blood pressure
- gene expression
- emergency department
- human health
- weight gain
- skeletal muscle
- risk assessment